The proliferation of vascular smooth muscle cells is a key event in the development of arterialle~ions:
In recent years, a wealth of information has accumulated concerning factors presumed to be important for the proliferation ofarterial smooth muscle cells in vitro and particular attention has been focused on how these factors might interact with the cells ofan injured arterial wall. Problems arise, however, in trying to use this in vitro data to predict the outcome of arterial injury since studies in this and other laboratories have shown that the in vivo and in vitro responses of the same cells in similar conditions can be markedly different. Because of these issues and because of the complexity of identifying all factors present in vivo, we have chosen to focus on understanding what circumstances are necessary for the initiation of smooth muscle cell growth in an artery and then to try to modify this response by the deletion or addition of defined factors. In this way, we hope to better understand what role particular factors may play in the proliferation ofsmooth muscle cells under normal physiological conditions. * Address correspondence to: Dr. Michael Reidy, Department of Pathology SJ-60, University of Washington, Seattle, Washington 98195.
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Loss OF ENDOTHELIUM
The most common experimental protocol to induce smooth muscle cell proliferation in vivo has been removal of the endothelium by some mechanical device, e.g., a balloon catheter (2) . This procedure causes a rapid increase in smooth muscle cell proliferation, and the migration of these cellsto form an intimal lesion (4, 5) . This result has been used to support the notion that vascular denudation accompanied by platelet mitogens playa key role in this process. In contrast to these data, we have found that limited endothelial cell loss, induced by a series ofdevices which appear to cause only minimal trauma to the medial cells, initiated no smooth muscle cell proliferation and no intimal lesions (Table I) (15, 16) . In an attempt to reconcile these apparently contradicting sets of data, we have tried to design experiments which focus on one particular element thought to participate in lesion formation and to determine if this factor is important in the response of the arterial wall to injury.
Platelets have long been thought to playa major role in initiating the proliferative response of smooth muscle cells (17) (18) (19) and, working in this laboratory, Jurgen Fingerle tested if the absence of platelets would influence intimal lesion development (7) . In 547 these experiments, rats were made thrombocytopenic by the use of an anti platelet antibody and the carotid arteries subjected to balloon catheter denudation. Control animals with normal platelet counts were subjected to balloon catheter denudation, which was followed by rapid platelet adherence to the subendothelium and, several hours later, a marked increase in smooth muscle cell proliferation.
In thrombocytopenic animals, however, no platelets adhered to the denuded arterial wall and yet the smooth muscle cell proliferation, as measured by 3H-thymidine autoradiography, exhibited an identical replication rate ( Fig. 1 ). Thus, it would appear that platelets do not influence the growth of smooth muscle cells after balloon catheter injury. One interesting aspect of these studies was that the growth of the intimal lesion in these 2 groups of animals was markedly different. Control animals showed small intimal lesions within 4 days postinjury but no lesions were found in the thrombocytopenic arteries. Even 7 days postinjury, a marked difference in the size of the intimal lesions was still noted ( 2). Therefore, loss of endothelium in conjunction with the presence of platelets would appear to influence the ability of medial cells to migrate into the media. Furthermore, it would appear that different factors control cell replication and cell movement since the smooth muscle cell proliferation in both groups was identical. Studies are now underway to try to define the factors thought to participate in these pathways.
A major issue arising from the above study is why does balloon catheter injury induce such a strong proliferative response by the smooth muscle cells when it appears that neither endothelial cell loss nor platelets appear to influence the proliferative rate of these cells. A pertinent fact to be considered in this discussion is that balloon catheter injury does far more than remove the endothelial cells and we previously have shown that a 20-25% loss of arterial wall DNA can be detected after such an injury (4). One possibility is that cell injury and cell death are responsible for the release offactors which influence smooth muscle cell proliferation. If there is any validity to this hypothesis, then elimination of trauma might influence the replication ofthe smooth muscle cells. We have recently developed a new denuding procedure which is equally effective as the balloon catheter in removing endothelial cells from arteries in vivo but does so without subjecting the medial smooth muscle cells to any detectable trauma (6) . A comparison ofthe arteries denuded by the balloon catheter and this new "gentle injury" procedure revealed some striking differences. Immediately after denudation with both gentle and balloon catheter denudation, there is a rapid expression in the tran- scripts for PDGF-A chain and TGF-{j with a transient decrease in platelet-derived growth factor (PDGF) receptor ({j subunit) ( Fig. 3 ). Platelets adhered to the exposed subendothelium and large platelet thrombi were often observed on arteries subjected to gentle denudation. Denudation with the balloon catheter initiated a smooth muscle cell proliferation ofapproximately 15%;yet, after the gentle denudation the 3H-thymidine index never exceeded 2%. This difference in smooth muscle cell proliferation was still detected several days postdenudation. Furthermore, at later times, a marked difference in the size of the intimal lesions was observed and, on average, the size of the intimal lesions from arteries subjected to gentle injury were 50% less than those observed in balloon catheter denuded vessels ( Fig. 4) . Thus, removal of endothelial cells, in a manner which does not traumatize the underlying media, markedly reduced the response of smooth muscle cells as compared to replication in cells from a balloon catheter denuded artery.
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The results ofthe above study raise an interesting question, namely, by what mechanism do these differing denuding techniques cause such different responses by the smooth muscle cell. Both procedures cause total loss of endothelium which is followed by platelet adherence and, therefore, it would seem unlikely that platelet factors influence this process. One possibility is that somehow the degree of trauma inflicted on the vessel is responsible for the observed results. At present, we are unclear as to what factors are involved but recently it has been suggested that bFGF may playa role in development of atherosclerotic lesions (10) . Basic fibroblast growth factor (FGF) is known to be present in the arterial wall and, because it has no signal sequence (1) , cell injury and death are thought to be a major pathway by which this mitogen is released. Balloon injury causes widespread smooth muscle cell death and so might release FGF into the arterial wall where it acts on smooth muscle cells. After gentle injury, no cell death is detected (6); therefore, little or no FGF release might be expected. Interestingly, this latter injury also causes a marked reduction in the proliferation of smooth muscle cells as compared to balloon catheter injury. Thus far, we have been unable to provide data to validate this hypothesis since effective FGF antagonists are not available for in vivo experiments; however, we have conducted studies to see ifFGF in vivo can stimulate smooth muscle cells. In studies carried out by Volkhard Linder in this laboratory, it was found that addition ofbFGF to animals denuded of endothelium caused an approximately lO-fold increase in the smooth muscle cell proliferation ( Fig. 5) (11) . Interestingly, when FGF was given to animals subjected to balloon catheter denudation, then smooth muscle cell replication was increased to approximately the same high rate. Furthermore, if FGF was administered repeatedly for a period of 2 weeks (12 fJ,g every 4 days) this was found to cause an approximate doubling in the size of the intimal lesions (Fig. 6 ) (11). One interesting aspect of these studies was that even repeated injections of bFGF had no effect on the growth of those smooth muscle cells ofuninjured arteries. This would suggest that either an intact endothelium acts as a permeability barrier and prevents influx of the mitogen to the arterial wall or that uninjured cells do not respond to the mitogen. In general, the above studies show that if FGF was released into the arterial wall then it would act as a potent mitogen and initiate smooth muscle cell proliferation. It should be noted that there is little direct evidence to support this hypothesis.
Thus far, the above studies show that widespread loss of endothelium (i.e., balloon or gentle denudation) leads to smooth muscle cell proliferation and intimal lesion formation. Smooth muscle cell proliferation, however, can occur without any intimal thickening. This can be seen after gentle injury where those denuded areas which are rapidly repopulated with new endothelial cells (< 7 days) do not go on to develop a thickened intima despite the fact that the smooth muscle cells have an identical rate of replication as those areas still denuded and with an identical proliferation rate (6) . These data again illustrate that the process of cell replication and cell movement are independently controlled. They also illustrate that the presence of endothelial cellswould appear to control the migration ofsmooth muscle cells into the intima. This fact might explain why no intimal thickening was observed in arteries when only limited zones of endothelium were removed (15) . Key features of these experiments were lack oftrauma to the underlying media and the rapid re-growth ofendothelium. These denuded sites were totally repopulated with new endothelial cells within 7 days and, extrapolating from the data with gentle injury, it is likely that their presence inhibited movements of smooth muscle cells from the media to the intima. Clearly, more work is required to validate this hypothesis but the results of the above experiments illustrate that the extent ofboth smooth muscle cell replication and the size of intimal lesions can be modified following vascular injury. These data may have some significance in the clinical setting where a relatively high frequency of re-occlusions occur after angioplasty.
Another potential mechanism of smooth muscle cell stimulation comes from the work ofSeifert and collaborators in which they showed that smooth muscle cells denied from young rats would secrete a PDGF-like peptide when grown in culture (20) . One possibility, therefore, is that smooth muscle cells can be stimulated by a paracrine or autocrine mechanism. To investigate this possibility, we isolated and grew in culture intimal cells from vessels which had previously been subjected to balloon catheter injury. These intimal cells were also found to express the mRNA for PDGF-B and to secrete a PDGF-like peptide (21) . In contrast, medial cells isolated from uninjured arteries showed no change in mRNA for PDGF nor secreted any PDGF. Thus, injury alters the phenotype of the smooth muscle cells such that they are able to synthesize PDGF. It is important to note that these studies were carried out in vitro and may not accurately reflect the changes present in vivo. Indeed, as is discussed in detail by Mark Majesky in the following paper (MW Majesky and SM Schwartz (1990) . Smooth muscle diversity in arterial wound repair. Toxicol. Pathol. 18: 554-559) , it is sometimes difficult to reconcile the in vitro data obtained from identical cells with the data obtained in vivo (12, 13) . Even with these caveats, it is possible that vascular smooth muscle cells can be stimulated to replicate by an autocrine mechanism.
PHARMACOLOGICAL INVESTIGAnON
Further insights into the factors controlling smooth muscle cell replication in vivo have come from stud- ies in which drugs have been used to inhibit specific cellular processes. Using the balloon catheter to injure the rat thoracic aorta, Jackson et al found that a number of antihypertensive drugs inhibit the initial wave of smooth muscle cell replication (8) . This antiproliferative effect is restricted to the injured vessel: no effect is seen in other tissues in which cellular replication occurs in a constitutive fashion, such as bone marrow, testis or duodenum (Table  II) . The compounds that exert this effect include the calcium antagonists nifedipine, verapamil and diltiazem; the potassium channel opener minoxidil; and the al-adrenoceptor antagonist prazosin. The antiproliferative and blood pressure-lowering effects of these compounds do not correlate, ruling out the possibility of an indirect effect on proliferation mediated through changes in the systemic blood pressure (Fig. 7) .
The inhibition of smooth muscle cell replication caused by nifedipine is also reflected in a reduction in the size of the neointima formed after balloon injury (Fig. 8) . There are several possible explanations for this result. The degree of smooth muscle cell proliferation in the media may be a controlling factor for the size of the resulting neointima, or perhaps in addition to its effects on replication, nifedipine also inhibits smooth muscle cell migration from the media to the intima, or it may inhibit smooth muscle cell proliferation after migration to the intima. The third alternative is the least likely, since the inhibitory effect of nifedipine on medial smooth muscle cell proliferation is only observed if the compound is administered between 8 and 30 h after balloon injury ( Fig. 9 ), which indicates that nifedipine interferes with a process early in the activation ofquiescent smooth muscle cells (9) .It seems likely that the reduction by nifedipine of neointima formation may be partially accounted for by inhibition of smooth muscle cell migration.
Nifedipine, like verapamil and diltiazem, is classified as a calcium antagonist. This means that it reduces the influx of'Ca'" ions into the smooth muscle cell via the L-type membrane calcium channel. This channel opens in response to membrane depolarisation and, therefore, is said to be voltageoperated. Minoxidil causes the membrane to hyperpolarise by stimulating the influx of'K" ions into the cell (14) and, therefore, has the effect of inhib-iting the influx of Car" ions via voltage-operated channels. We may, therefore, conclude that the influx of Cat" ions into medial smooth muscle cells via the L-type channel is an obligatory step in the replication of quiescent smooth muscle cells after balloon catheter injury. However, this conclusion begs the question of what stimulates the entry of Car" ions by this route in the first place. One candidate is noradrenaline, which is a potent contractile agonist in rat thoracic aorta in vitro. The contraction produced by noradrenaline, which is the result of stimulation of the al-adrenoceptor, is strongly inhibited by nifedipine, suggesting that it is largely mediated by Car" ion influx through L-type channels (3). Since the a1-adrenoceptor antagonist prazosin inhibited smooth muscle cell proliferation after balloon injury, we speculate that, in this model, noradrenaline is an important mediator of proliferation. Whether it is a direct mitogen, or potentiates other mitogens, is open to question.
